# Zilver PTX Post-Market Study in Japan

Study · id `cardio:ct-nct02254837` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02254837](<https://clinicaltrials.gov/study/NCT02254837>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02254837

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 909 participants.

## Technical summary

Registry record NCT02254837. Allocation not applicable; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2018-06-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 909 participants (enrolled count; ClinicalTrials.gov record NCT02254837, source copy `cardio:ctgov-nct02254837-2019-07-12`, retrieved 2026-10-31)
- Start date: 2012-05 (registry gives no type) (ClinicalTrials.gov record NCT02254837, source copy `cardio:ctgov-nct02254837-2019-07-12`, retrieved 2026-10-31)
- Primary completion: 2018-06-30 (actual) (ClinicalTrials.gov record NCT02254837, source copy `cardio:ctgov-nct02254837-2019-07-12`, retrieved 2026-10-31)
- Completion: 2018-06-30 (actual) (ClinicalTrials.gov record NCT02254837, source copy `cardio:ctgov-nct02254837-2019-07-12`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02254837-2019-07-12`, retrieved 2026-10-31)

## The registry's words

- Brief title: Zilver PTX Post-Market Study in Japan
- Condition: Peripheral Arterial Disease (PAD)
- Intervention (Device): Zilver PTX Drug-Eluting Stent
- Lead sponsor: Cook Group Incorporated
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Cook Group Incorporated (`cardio:org-cook-group-incorporated`)

## Provenance

Content hash: 4129ee86977d99e5d0e26f791c495cb3561b47ac4a44c7dbb32d43e13ef44a75
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
